Track topics on Twitter Track topics that are important to you
Thursday, September 22nd 2016 at 10:00pm UTC CAMBRIDGE, Mass.–(BUSINESS WIRE)– Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a developer of innovative RNA-targeted therapeutics, today announced that it has priced an underwritten public offering of an aggregate of 5.02 million shares of its common stock at a price to the public of $59.75 per share. In addition, Sarepta …
Cet article Sarepta Therapeutics Announces Pricing of $300 Million Public
Offering of Common Stock est apparu en premier sur EEI-BIOTECHFINANCES.